Association of anti-phosphatidylserine/prothrombin antibodies with adverse in vitro fertilization outcomes
Journal of Reproductive Immunology · 2025
DOI: 10.1016/j.jri.2025.104429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Reproductive Immunology, 2025. Verfasst von Dongyan Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive and Genetic Center, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology …. Hauptthemen laut MEDLINE: Fertilization in Vitro, Infertility, Female, Antiphospholipid Syndrome, Antibodies, Antiphospholipid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Anti-phosphatidylserine/prothrombin antibodies (aPS/PT) are classified as non-criteria antiphospholipid antibodies (aPL), and are strongly associated with thrombosis and pregnancy complications linked to antiphospholipid syndrome (APS). This study aimed to investigate whether aPS/PT positivity is associated with adverse outcomes in vitro fertilization (IVF). The study included infertile women who tested positive aPS/PT and underwent IVF cycles, as well as infertile controls with pure tubal etiology. We compared the impact of aPS/PT on baseline and clinical characteristics, immune-related indicators, IVF laboratory metrics, and pregnancy outcomes. Women with aPS/PT exhibited lower numbers of retrieved oocytes, embryos, and both perfect and available embryos, as well as reduced rates of blastocyst formation. Furthermore, an imbalanced Th17/Treg ratio and significantly elevated serum IL-17A levels were observed in women with aPS/PT compared to controls. In conclusion, the presence of aPS/PT is associated with adverse IVF and pregnancy outcomes. Early screening for aPS/PT and appropriate consultation for couples undergoing IVF-ET should be considered. Additionally, specific immune and inflammatory mechanisms related to aPS/PT warrant further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Reproductive and Genetic Center, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230026, China; University of Science and Techno…
- Reproductive and Genetic Center, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230026, China.
- Reproductive Medicine and Immunology, Obstetrics and Gynecology, Clinical Sciences Department, Chicago Medical School, Rosalind Franklin University of Medicine and Science, Vernon Hills, IL 60061, USA; Center for Cancer…
- Reproductive and Genetic Center, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230026, China. Electronic address: wuli.0722@fs…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, D., Wang, Y., Zhang, Y., Wang, H., Tang, W., Duan, X., Wang, R., Hu, M., Lu, F., Kwak-Kim, J., & Wu, L. (2025). Association of anti-phosphatidylserine/prothrombin antibodies with adverse in vitro fertilization outcomes. Journal of Reproductive Immunology. https://doi.org/10.1016/j.jri.2025.104429
Vancouver
Liu D, Wang Y, Zhang Y, Wang H, Tang W, Duan X, et al. Association of anti-phosphatidylserine/prothrombin antibodies with adverse in vitro fertilization outcomes. Journal of Reproductive Immunology. 2025. doi:10.1016/j.jri.2025.104429
BibTeX
@article{Liu2025,
author = {Liu, Dongyan and Wang, Yanshi and Zhang, Yu and Wang, Haoyu and Tang, Wenjuan and Duan, Xiaoyu and Wang, Ru and Hu, Meihong and Lu, Fangting and Kwak-Kim, Joanne and Wu, Li},
title = {Association of anti-phosphatidylserine/prothrombin antibodies with adverse in vitro fertilization outcomes},
journal = {Journal of Reproductive Immunology},
year = {2025},
doi = {10.1016/j.jri.2025.104429}
}
EUVIMED